2022 Annual Shareholder Meeting and Director Nominations

MEETING
Thu, Jun 02 2022 02:53 pm

2 June 2022

2022 Annual Shareholder Meeting and Director Nominations

Blis Technologies Limited’s 2022 Annual Shareholder Meeting will be held at Dunedin Public Art Gallery, Auditorium, 30 The Octagon, Dunedin and online at www.virtualmeeting.co.nz/blt22 on Thursday 21 July 2022 commencing at 11.00am.

The closing date for nominations by shareholders of directors to be considered for election at the Annual Shareholder Meeting is Friday, 17 June 2022.

Nominations may only be made by a shareholder entitled to attend and vote at the Annual Shareholder Meeting and must be accompanied by a consent in writing by the nominated person.

Nominations should be addressed by mail or email to:

Richard Wingham
Chief Financial Officer
Blis Technologies Limited
PO Box 2208
Dunedin 9044

Email: [email protected]

Notice of the Annual Shareholder Meeting will be released to the NZX along with instructions for attending the virtual meeting, at least 20 working days prior to the meeting.

Ends

For further information, please contact:
Richard Wingham
Chief Financial Officer
+64 21 284 0446

About Blis Technologies Ltd

Delivering proven health benefits through evidence-based, advanced probiotics
Blis Technologies is an NZX-listed manufacturer of advanced probiotic strains that go beyond the gut. Combining innovation with evidence-based research and the highest quality production controls enables the delivery of probiotic solutions for specific health targets including throat health, halitosis (bad breath), immune support, teeth and gum health and skin health. BLIS® products are sold throughout New Zealand and in Australia, Asia, Europe and the USA. More information about Blis Technologies Ltd can be found at www.blis.co.nz.

Website: www.unconditionalskin.com
Instagram: @unconditionalskin #BLISQ24 #USC
Facebook: @unconditionalskin


Announcement PDF


Markets News

Warehouse drops guidance, loss now in scope
Retail

Warehouse drops guidance, loss now in scope

The retailer has raised the possibility of a full-year earnings loss.

Markets Analysis

Xero’s Melio ‘leap of faith’

The NZ-founded company’s giant-killer dreams in the US hinge on this huge bet. 

Xero’s Melio ‘leap of faith’
Markets Market Close

NZX ends half year down 3.6%

"We’ve continued to lag relative to other markets," analyst says.

Gregor Thompson 30 Jun 2025
NZX ends half year down 3.6%